Thus, BAFF-APRIL maintains a balance of inflammatory (producing autoantibody and inflammatory cytokines) and anti-inflammatory (producing IL-10) B cells, the disruption of which can lead to MS. Here, TNFSF13 is linked to myeloid sarcoma.